Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

INTRODUCTION: Next‐generation sequencing (NGS) and digital polymerase chain reaction (PCR) based platforms have been used to detect EGFR mutations in plasma circulating tumor DNA (ctDNA) with high accuracy. Generally, molecular testing is performed after histopathological analysis. However, many pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Qinfang, Fang, Qiyu, Sun, Hui, Singh, Aditi P., Alexander, Mariam, Li, Shenduo, Cheng, Haiying, Zhou, Songwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064093/
https://www.ncbi.nlm.nih.gov/pubmed/31991049
http://dx.doi.org/10.1002/cam4.2869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064093/
https://www.ncbi.nlm.nih.gov/pubmed/31991049
http://dx.doi.org/10.1002/cam4.2869

Ejemplares similares